Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: Research Summary.

Stereotactic MRI-guided adaptive radiation therapy (SMART) for locally advanced pancreatic cancer: A prospective single-center cohort study.

SRS/SBRT commissioning process with a hybrid beam data model in new preconfigured CyberKnife system.

Ultrafast proton delivery with pin ridge filters (pRFs): repurposing single-energy delivery for motion management in proton therapy.

MPLA case: A proposal for purchasing SRS/SBRT QA equipment.

Evaluation of cases with over 10 years of follow-up after stereotactic body radiotherapy for Stage I lung cancer.

Clinical outcomes and blood-based biomarkers across two SABR-treated metastatic settings: oligoprogression under immune checkpoint inhibition and oligometastatic disease.